Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Aligos Therapeutics (ALGS) Shares Issued (2021 - 2025)

Aligos Therapeutics filings provide 5 years of Shares Issued readings, the most recent being $124000.0 for Q4 2025.

  • On a quarterly basis, Shares Issued fell 10.79% to $124000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $263000.0, a 187.96% increase, with the full-year FY2025 number at $304000.0, down 30.28% from a year prior.
  • Shares Issued hit $124000.0 in Q4 2025 for Aligos Therapeutics, down from $139000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $720000.0 in Q4 2021 to a low of -$438000.0 in Q3 2023.
  • Median Shares Issued over the past 5 years was $101000.0 (2022), compared with a mean of $118307.7.
  • Biggest five-year swings in Shares Issued: crashed 605.56% in 2022 and later soared 333.66% in 2023.
  • Aligos Therapeutics' Shares Issued stood at $720000.0 in 2021, then tumbled by 74.31% to $185000.0 in 2022, then crashed by 336.76% to -$438000.0 in 2023, then soared by 131.74% to $139000.0 in 2024, then fell by 10.79% to $124000.0 in 2025.
  • The last three reported values for Shares Issued were $124000.0 (Q4 2025), $139000.0 (Q4 2024), and -$438000.0 (Q3 2023) per Business Quant data.